Harvard licenses health content to Microsoft to improve Copilot

Harvard Medical School has entered a licensing agreement with Microsoft, granting the tech firm access to Harvard Health Publishing’s consumer-focused medical content on diseases and wellness, with Microsoft paying a licensing fee.

The material is intended to strengthen healthcare-related answers in Copilot and related services with clinically reviewed sources.

A move to bolster trustworthy health answers

Microsoft has said the Harvard content has been aimed at improving the accuracy and reliability of health responses generated by its Copilot assistant.

The agreement covers consumer health education assets produced by Harvard Health Publishing (a division of Harvard Medical School).

HHP has offered medically reviewed content spanning condition-specific topics (such as heart disease, diabetes and back pain) and wellness programmes (including sleep, exercise and nutrition). Its licensed content is available via APIs and XML feeds for partners.

Harvard has also reminded readers that its materials are for personal use and should not substitute for direct medical advice from a clinician guidance that has applied whether content appears on Harvard’s own site or through third‑party platforms.

Why it matters

Grounding generative AI in authoritative sources has been a key priority across the sector, following concerns about large language models producing inconsistent or unsafe medical advice.

The licensing deal has formed part of Microsoft’s push to expand healthcare offerings and reduce dependence on a single model provider.

Alongside its long‑running collaboration with OpenAI, Microsoft has begun integrating alternatives such as Anthropic’s Claude and has been developing its own models. Leadership across Microsoft AI, including CEO Mustafa Suleyman, has been steering this diversification.

Under CEO Satya Nadella, Microsoft has also embedded Copilot across its productivity and industry clouds, with healthcare among the earliest focus areas.